Tech Company Financing Transactions

iOnctura Funding Round

Syncona, 3B Future Health Fund and European Innovation Council Fund invested in a $85.5 million Series B funding round for iOnctura. This VC investment round was announced by the company on 6/20/2024.

Transaction Overview

Company Name
Announced On
6/20/2024
Transaction Type
Venture Equity
Amount
$85,500,000
Round
Series B
Proceeds Purpose
The company intends to use the funds to accelerate the development of lead asset roginolisib for treatment of uveal melanoma and a number of other oncology indications. iOnctura plans to commence trials in other cancer indications, including non-small cell lung cancer and primary myelofibrosis, later in 2024.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Campus Biotech Innovation Park Avenue Sécheron 15
Genève, 1202
CH
Phone
Undisclosed
Email Address
Overview
Founded in June 2017, iOnctura is a clinical stage biopharmaceutical company focused on delivering innovative cancer treatments to patients with unmet medical need. iOnctura is uncovering the key to unlock difficult to treat tumors burdened by stroma and immune mediated resistance. We do this by simultaneously targeting multiple tumor survival mechanisms with a single drug, disrupting the dynamic interplay at the heart of the tumor-stroma-immune interface.
Profile
iOnctura LinkedIn Company Profile
Social Media
iOnctura Company Twitter Account
Company News
iOnctura News
Facebook
iOnctura on Facebook
YouTube
iOnctura on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Catherine Pickering
  Catherine Pickering LinkedIn Profile  Catherine Pickering Twitter Account  Catherine Pickering News  Catherine Pickering on Facebook
Chief Financial Officer
David SEEBERGER
  David SEEBERGER LinkedIn Profile  David SEEBERGER Twitter Account  David SEEBERGER News  David SEEBERGER on Facebook
Chief Marketing Officer
Michael LAHN
  Michael LAHN LinkedIn Profile  Michael LAHN Twitter Account  Michael LAHN News  Michael LAHN on Facebook
Chief Technical Officer
Lars Veen
  Lars Veen LinkedIn Profile  Lars Veen Twitter Account  Lars Veen News  Lars Veen on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/20/2024: Molten Industries venture capital transaction
Next: 6/20/2024: PQShield venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary